Side by Side Cedars Sinai

Side by Side Cedars Sinai

Side by Side Cedars-Sinai Skip to content Close Select your preferred language English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog Menu Close Call 1-800-CEDARS-1 toggle search form Close Share Email Print discoveries magazine Discoveries Side by Side Oct 22, 2020 Sherry Angel Share Tweet Post Illustration: David Mahoney Mary Wong Lee was one of the first patients to receive an experimental vaccine for an aggressive form of brain cancer. When they met as students at the University of California, Davis, in the 1970s, her first thought was: He’s not my type. Mary Wong Lee was from a conservative, rural community in Central California, and Ed Lee was a long-haired hippie from Los Angeles. He was spellbound from the start. "He kept coming around," Mary says. "Now I’m stuck with him." "We like to rib each other," Ed adds. Married 45 years, the San Dimas, California, couple does just about everything side by side. "We still enjoy every day together," Mary says. "I guess we don’t fit the statistics." She was referring to their unusually long relationship. But she could have been talking about beating the odds in an even bigger way. In 2006, Mary was diagnosed with glioblastoma, the deadliest form of brain cancer. But she was in the right place at the right time. Her doctor, Keith Black, MD, chair of the Department of Neurosurgery at Cedars-Sinai, was developing a vaccine designed to activate the immune system to fight glioblastoma. Mary, who is 68, was one of the first patients to receive this investigative therapy in an early clinical trial. Typically, fewer than 3% of people diagnosed with glioblastoma live five years, but half of those treated with the experimental vaccine in the small phase I study survived longer. The vaccine is now in a third phase clinical trial involving patients at more than 100 medical centers worldwide. Black, director of the Maxine Dunitz Neurosurgical Institute and the Ruth and Lawrence Harvey Chair in Neuroscience, notes that, while median survival for glioblastoma is about a year and a half, "we now have patients living past 10 years." That, of course, includes Mary. For her, this added time meant being able to attend her two sons’ college graduations and weddings, getting to know her two grandsons and having more time with a devoted husband whose jokes still make her laugh. Her cancer returned five years ago, but the tumor was small and she responded well to surgery and chemotherapy. Today, she says: "I’m fine. I’m happy. I don’t walk as quickly as I used to, and I’m a little slower reading, but I’m still here to boss Ed around." They have breakfast and read the newspaper together, accompany each other on errands, and share quiet time as Mary knits and Ed reads. She has always been a great cook, and he has become her sous chef. "We focus on the simple joys of living," she says. Ed, who sees those joys as profound, chokes up as he describes his wife. "She is strong and beautiful. And she’s a fighter," he says. "You can’t help waiting for the other shoe to drop with this cancer, but she always stays positive. Fourteen years later, here we are. I’m very fortunate that she has gotten used to me over the years." Tags features Innovation Patient Stories Scientists Fall 2020 Share Tweet Post Blog & Magazines catalyst Blog & Magazines Home CS-Blog Blog CS Magazine Cedars-Sinai Magazine discoveries magazine Discoveries Magazine Embracing our Community Embracing Our Community Blog & Magazines catalyst Blog & Magazines Home CS-Blog Blog Embracing our Community Embracing Our Community CS Magazine Cedars-Sinai Magazine discoveries magazine Discoveries Magazine Popular Topics Patients Scientists Innovations Quick Reads Weird Science Make an Appointment Find a Doctor Schedule a Callback Call us 24 hours a day 1-800-CEDARS-1 Support Cedars-Sinai MAKE A GIFT VOLUNTEER Share Email Print Please ensure Javascript is enabled for purposes of website accessibility
Share:
0 comments

Comments (0)

Leave a Comment

Minimum 10 characters required

* All fields are required. Comments are moderated before appearing.

No comments yet. Be the first to comment!